ID
41452
Beschrijving
Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases
Trefwoorden
Versies (1)
- 13-10-20 13-10-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
13 oktober 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073
Survival Follow-Up
- StudyEvent: ODM
Beschrijving
Survival Follow-Up
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C0038952
Beschrijving
Alive (finding)
Datatype
text
Alias
- UMLS CUI [1]
- C2584946
Beschrijving
Alive (finding), Date last contact
Datatype
date
Alias
- UMLS CUI [1,1]
- C2584946
- UMLS CUI [1,2]
- C0805839
Beschrijving
Cancer treatment, New
Datatype
text
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0205314
Beschrijving
Cancer treatment, New, Start Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0205314
- UMLS CUI [1,3]
- C0808070
Similar models
Survival Follow-Up
- StudyEvent: ODM
C2985720 (UMLS CUI-2)
C2985720 (UMLS CUI [2])
C0038952 (UMLS CUI-2)
C0805839 (UMLS CUI [1,2])
C0205314 (UMLS CUI [1,2])
C0205314 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])